| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Director | Common Stock | 119K | $1.87M | $15.74 | Aug 10, 2024 | Direct |
| NEOGENOMICS INC | Director | Stock Option (Right to Buy) | 8.67K | $381K | $43.95 | Aug 10, 2024 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 12.3K | $193K | $15.74 | Jun 1, 2024 | Direct |
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 81.3K | $92.6K | $1.14 | May 25, 2024 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Common Stock | 31.9K | $44K | $1.38 | Jul 20, 2022 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Performance Stock Units (PSUs) | 30K | $41.4K | $1.38 | Oct 24, 2021 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 0 | $0 | $15.74 | Aug 10, 2024 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 135K | Feb 2, 2022 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 30K | May 25, 2024 | Direct | ||
| NEOGENOMICS INC | Director | Stock Options (Right to Buy) | 3.45K | Aug 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Aug 10, 2024 | 2 | $0 | 4 | Aug 13, 2024 | Director |
| NEO | NEOGENOMICS INC | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 25, 2024 | 2 | $0 | 4 | May 29, 2024 | Director |
| NEO | NEOGENOMICS INC | Aug 10, 2023 | 2 | $0 | 4 | Aug 14, 2023 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 26, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Director |
| CTMX | CytomX Therapeutics, Inc. | Jul 19, 2022 | 2 | -$7.97K | 4 | Jul 21, 2022 | Chief Medical Officer |
| NEO | NEOGENOMICS INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 20, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
| CTMX | CytomX Therapeutics, Inc. | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Medical Officer |
| CTMX | CytomX Therapeutics, Inc. | Oct 24, 2021 | 2 | $0 | 4 | Oct 26, 2021 | Chief Medical Officer |
| NEO | NEOGENOMICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 19, 2021 | 2 | $0 | 4 | May 21, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 14, 2021 | 0 | $0 | 3 | May 18, 2021 | Director |